| Product Code: ETC6106946 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola VMAT2 Inhibitors Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola VMAT2 Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Angola VMAT2 Inhibitors Market - Industry Life Cycle |
3.4 Angola VMAT2 Inhibitors Market - Porter's Five Forces |
3.5 Angola VMAT2 Inhibitors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Angola VMAT2 Inhibitors Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Angola VMAT2 Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Angola |
4.2.2 Growing awareness about the benefits of VMAT2 inhibitors in managing neurological conditions |
4.2.3 Favorable government policies supporting the development and accessibility of VMAT2 inhibitors |
4.3 Market Restraints |
4.3.1 High cost associated with VMAT2 inhibitors leading to affordability issues for patients |
4.3.2 Limited healthcare infrastructure and resources in Angola impacting the distribution and availability of VMAT2 inhibitors |
5 Angola VMAT2 Inhibitors Market Trends |
6 Angola VMAT2 Inhibitors Market, By Types |
6.1 Angola VMAT2 Inhibitors Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Angola VMAT2 Inhibitors Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Angola VMAT2 Inhibitors Market Revenues & Volume, By Tetrabenazine, 2021- 2031F |
6.1.4 Angola VMAT2 Inhibitors Market Revenues & Volume, By Valbenazine, 2021- 2031F |
6.1.5 Angola VMAT2 Inhibitors Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Angola VMAT2 Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Angola VMAT2 Inhibitors Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.2.3 Angola VMAT2 Inhibitors Market Revenues & Volume, By Tardive Dyskinesia, 2021- 2031F |
6.2.4 Angola VMAT2 Inhibitors Market Revenues & Volume, By Other, 2021- 2031F |
7 Angola VMAT2 Inhibitors Market Import-Export Trade Statistics |
7.1 Angola VMAT2 Inhibitors Market Export to Major Countries |
7.2 Angola VMAT2 Inhibitors Market Imports from Major Countries |
8 Angola VMAT2 Inhibitors Market Key Performance Indicators |
8.1 Number of healthcare facilities offering VMAT2 inhibitors in Angola |
8.2 Percentage increase in the prescription rate of VMAT2 inhibitors |
8.3 Patient adherence rate to VMAT2 inhibitor treatment |
8.4 Number of clinical trials and research studies on VMAT2 inhibitors in Angola |
9 Angola VMAT2 Inhibitors Market - Opportunity Assessment |
9.1 Angola VMAT2 Inhibitors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Angola VMAT2 Inhibitors Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Angola VMAT2 Inhibitors Market - Competitive Landscape |
10.1 Angola VMAT2 Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Angola VMAT2 Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |